Objectives: To evaluate the safety, efficacy, and invasiveness of lobectomy by video-assisted thoracoscopicsurgery (VATS) in the treatment of stage I/II non-small cell lung cancer (NSCLC). Methods: A total of 148patients presenting with Stage I or II NSCLC were enrolled into our study, comprising 71 who underwent VATSand 77 patients undergoing conventional thoracotomic lobectomy, in combination with systematic lymph noderesection. Results: It was found that VATS was superior to conventional thoracotomy in terms of the durationof surgery, intraoperative blood loss, frequency of the need to administer postoperative analgesia, thoracicintubation indwelling time, post-operative hospital stay, and survival rate (P<0.05). We saw no obvious differencein the number of resected lymph nodes with either approach. Conclusions: VATS lobectomy is a safe and reliablesurgical approach for the treatment of Stage I/II NSCLC, characterized by significantly minimal invasiveness,rapid post-operative recovery, and markedly lower loss of blood.
(2013). Video-assisted Thoracoscopic Surgery for Treatment of Earlystage Non-small Cell Lung Cancer. Asian Pacific Journal of Cancer Prevention, 14(5), 2871-2877.
MLA
. "Video-assisted Thoracoscopic Surgery for Treatment of Earlystage Non-small Cell Lung Cancer". Asian Pacific Journal of Cancer Prevention, 14, 5, 2013, 2871-2877.
HARVARD
(2013). 'Video-assisted Thoracoscopic Surgery for Treatment of Earlystage Non-small Cell Lung Cancer', Asian Pacific Journal of Cancer Prevention, 14(5), pp. 2871-2877.
VANCOUVER
Video-assisted Thoracoscopic Surgery for Treatment of Earlystage Non-small Cell Lung Cancer. Asian Pacific Journal of Cancer Prevention, 2013; 14(5): 2871-2877.